• Cellvizio®
    • Overview
    • Education
    • Economics
    • Indications
      • Gastroenterology
        • Barrett’s Esophagus
        • Pancreatic Cysts
        • Gastric Disease
        • Inflammatory Bowel Diseases
        • Irritable Bowel Syndrome – Food Intolerance
        • Bilio-Pancreatic Strictures
        • Colorectal Lesions
      • Pulmonology
        • Lung Nodules
        • Lung Transplant
      • Urology
  • Investors
    • Overview
    • Events and Presentations
    • Financials
    • Governance
  • About Us
    • Our Story
    • Team
      • Board of Directors
      • Leadership Team
    • Join Us
    • Commercial network
  • Newsroom
    • News
    • Events
    • Press Coverage
  • INT
    • US
    • FR
Mauna Kea Technologies Announces the Installation of Cellvizio® at University College Cork – APC Microbiome Ireland for Inflammatory Bowel Disease (IBD) Applications

Mauna Kea Technologies Announces the Installation of Cellvizio® at University College Cork – APC Microbiome Ireland for Inflammatory Bowel Disease (IBD) Applications

by Zina | Jul 3, 2023 | News

Paris and Boston, July 3, 2023 – 5:45 p.m. CEST – Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces that Cellvizio is being...
Mauna Kea Technologies: release of the 2022 Universal Registration Document

Mauna Kea Technologies: release of the 2022 Universal Registration Document

by Zina | Jun 30, 2023 | News

Paris and Boston, June 30, 2023 – 5:45 p.m. CEST – Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, announces that it has made available to the...
UC Davis Health offers new procedures thanks to state-of-the-art endoscopy suite

UC Davis Health offers new procedures thanks to state-of-the-art endoscopy suite

by Zina | Jun 15, 2023 | Press Coverage

“This new suite is equipped with state-of-the-art equipment that allows us to provide the cutting-edge, minimally invasive procedures that UC Davis Health is known for,” said Antonio Mendoza-Ladd, medical director of endoscopy...
Mauna Kea Technologies: release of the 2022 Universal Registration Document

Mauna Kea Technologies Announces the Appointment of Côme de La Tour du Pin as its Chief Financial Officer

by Zina | Jun 13, 2023 | News

Paris and Boston, June 13, 2023 – 5:45 p.m. CEST – Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the appointment of...
Mauna Kea Technologies: release of the 2022 Universal Registration Document

Mauna Kea Technologies Announces the Launch of the Transfer of its Shares to Euronext Growth Paris

by Zina | Jun 8, 2023 | News

Paris and Boston, June 8, 2023 – 5:45 PM CEST – Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces that the Combined General...
« Older Entries
Next Entries »

Articles récents

  • Mauna Kea Technologies announces results of its Combined General Meeting of June 5, 2025 
  • Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification 
  • Mauna Kea Technologies Provides Update on Safeguard Proceedings, Strategic Discussions and Operational Progress 
  • Mauna Kea Technologies announces the availability of preparatory documents for the Combined General Meeting of June 5, 2025 and the instructions for participation 
  • Mauna Kea Technologies Announces Largest Annual Pancreatic Cyst Consortium at Digestive Disease Week® 2025 

Commentaires récents

No comments to show.

Company Info

About Us

Join Us

Contact Us

Legal

Legal notice

Privacy policy

Our websites

Cellvizio.net

cell-tolerance.com

Diagnosingbarretts.org

Diagnosingpancreaticcysts.org

Follow us

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}